MOLN
Molecular Partners AG ADRNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$166.48M
P/E Ratio
—
EPS
$-2.10
Beta
0.74
52W High
$5.36
52W Low
$3.41
50-Day MA
$4.50
200-Day MA
$4.11
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
1.70
PEG Ratio
—
About Molecular Partners AG ADR
Molecular Partners AG is a clinical-stage biopharmaceutical company. The company is headquartered in Schlieren, Switzerland.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-39.14M |
| EBITDA | $-54.54M |
| Operating Margin | 0.00% |
| Return on Equity | -55.50% |
| Return on Assets | -26.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.73 |
| Price-to-Book | 1.63 |
| Price-to-Sales (TTM) | 156.56 |
| EV/Revenue | 3.814 |
| EV/EBITDA | 1.24 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $37.41M |
| Float | $19.82M |
| % Insiders | 0.00% |
| % Institutions | 9.60% |
Historical Volatility
HV 10-Day
37.25%
HV 20-Day
52.20%
HV 30-Day
51.90%
HV 60-Day
49.65%
HV Rank
33.7%
Volatility is currently contracting
Analyst Ratings
Consensus ($11.10 target)
4
Buy1
HoldData last updated: 4/30/2026